Related references
Note: Only part of the references are listed.Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy
Eisuke Murakami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent
Robert G. Gish et al.
ANTIVIRAL RESEARCH (2015)
Host-virus interactions in hepatitis B virus infection
Luca G. Guidotti et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Parallel 4: Hepatitis B: Novel Treatments and Treatment Targets
HEPATOLOGY (2015)
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J. Gane et al.
JOURNAL OF HEPATOLOGY (2015)
Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection
Tracy D. Reynolds et al.
JOURNAL OF VIROLOGY (2015)
Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment
Edward M. Kennedy et al.
VIROLOGY (2015)
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
Perrine Martin et al.
GUT (2015)
Induced immunity against hepatitis B virus
Zeinab Nabil Ahmed Said et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases
Samantha A. Nicholson et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Marcela V. Maus et al.
BLOOD (2014)
Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients
Mohammad Momeni et al.
HUMAN IMMUNOLOGY (2014)
An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases
Jieliang Chen et al.
MOLECULAR THERAPY (2014)
AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
Nicholas D. Weber et al.
PLOS ONE (2014)
A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance
Thomas H. King et al.
PLOS ONE (2014)
Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir
Amy C. Sherman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly
Guoyi Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
T Cells Expressing a Chimeric Antigen Receptor That Binds Hepatitis B Virus Envelope Proteins Control Virus Replication in Mice
Karin Krebs et al.
GASTROENTEROLOGY (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: A clinical study
Peng Ruan et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
Antonio Bertoletti et al.
POSTGRADUATE MEDICAL JOURNAL (2013)
Assembly-Directed Antivirals Differentially Bind Quasiequivalent Pockets to Modify Hepatitis B Virus Capsid Tertiary and Quaternary Structure
Sarah P. Katen et al.
STRUCTURE (2013)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication
Gaetan Billioud et al.
ANTIVIRAL RESEARCH (2011)
Genome Engineering With Zinc-Finger Nucleases
Dana Carroll
GENETICS (2011)
Design, Synthesis, and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion
Wenquan Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice
Nicolas Brezillon et al.
PLOS ONE (2011)
HBsAg Seroclearance: Prognostic value for the response to treatment and the long-term outcome
R. Moucari et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2010)
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
Paola Fisicaro et al.
GASTROENTEROLOGY (2010)
Durability of Peginterferon alfa-2b Treatment at 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Vincent Wai-Sun Wong et al.
HEPATOLOGY (2010)
Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAs
Thomas J. Cradick et al.
MOLECULAR THERAPY (2010)
HBsAg inhibits TLR9-mediated activation and IFN-α production in plasmacytoid dendritic cells
Yongfen Xu et al.
MOLECULAR IMMUNOLOGY (2009)
The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells
Marjoleine L. Op den Brouw et al.
VIROLOGY (2009)
Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly
Guo-Yi Wu et al.
JOURNAL OF CHEMOTHERAPY (2008)
Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture
Kimberley A. Zimmerman et al.
JOURNAL OF VIROLOGY (2008)
RNAi for treating hepatitis B viral infection
Yong Chen et al.
PHARMACEUTICAL RESEARCH (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion
Anne Marie Dougherty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
J. J. Feld et al.
ANTIVIRAL RESEARCH (2007)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Stealth and cunning: Hepatitis B and hepatitis C viruses
SF Wieland et al.
JOURNAL OF VIROLOGY (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA
F Zoulim
JOURNAL OF HEPATOLOGY (2005)
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
P Gripon et al.
JOURNAL OF VIROLOGY (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Inhibition of hepatitis B virus in mice by RNA interference
AP McCaffrey et al.
NATURE BIOTECHNOLOGY (2003)
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids
K Deres et al.
SCIENCE (2003)
Hepatitis B virus biology
C Seeger et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Share Paper
